Nymox Pharmaceutical Quote - NYMX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.20

Bid

0.2003

Ask

0.2169

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

18.708M

Previous Close

0.20

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

93,540,000

Dividend Yield

PE Ratio

-2.12

Earnings Per Share (EPS)

-0.09

Revenue

Net Profit

-8.84M

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.

Sector

Chemicals & Chem Preps, Nec

Industry

Chemicals & Chem Preps, Nec

Website

www.nymox.com

Headquarters

Nassau, Bhs

Founded

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NYMX - Frequently Asked Questions (FAQ)

What is the current Nymox Pharmaceutical share price?

The current share price of Nymox Pharmaceutical is US$ 0.20

How many Nymox Pharmaceutical shares are in issue?

Nymox Pharmaceutical has 93,540,000 shares in issue

What is the market cap of Nymox Pharmaceutical?

The market capitalisation of Nymox Pharmaceutical is USD 18.71M

What is the 1 year trading range for Nymox Pharmaceutical share price?

Nymox Pharmaceutical has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Nymox Pharmaceutical?

The price to earnings ratio of Nymox Pharmaceutical is -2.12

What is the reporting currency for Nymox Pharmaceutical?

Nymox Pharmaceutical reports financial results in USD

What is the latest annual profit for Nymox Pharmaceutical?

The latest annual profit of Nymox Pharmaceutical is USD -8.84M

What is the registered address of Nymox Pharmaceutical?

The registered address for Nymox Pharmaceutical is BAY & DEVEAUX STS., 2ND FLOOR, NASSAU, H4M 2V2

What is the Nymox Pharmaceutical website address?

The website address for Nymox Pharmaceutical is www.nymox.com

Which industry sector does Nymox Pharmaceutical operate in?

Nymox Pharmaceutical operates in the CHEMICALS & CHEM PREPS, NEC sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BOXLBoxlight Corporation	US$ 1.645 (257.61%)	240.38M
SPRCSciSparc Ltd	US$ 1.06 (100.80%)	190.41M
XTIAXTI Aerospace Inc	US$ 0.08261 (99.54%)	1.56B
DHAIDIH Holdings US Inc	US$ 2.8602 (82.18%)	4.67M
NXPLNextPlat Corporation	US$ 1.73 (61.68%)	12.6M
RGFReal Good Food Company Inc	US$ 1.31 (-63.49%)	1.47M
LUNALuna Innovations Incorporated	US$ 0.8744 (-57.35%)	12.29M
GCTKGlucoTrack Inc	US$ 0.1594 (-45.65%)	35.76M
ACONAclarion Inc	US$ 0.1699 (-43.06%)	35.05M
BLRXBioLineRx Ltd	US$ 0.1621 (-40.80%)	44.6M
XTIAXTI Aerospace Inc	US$ 0.08261 (99.54%)	1.56B
NVDANVIDIA Corporation	US$ 149.43 (3.43%)	264.32M
CNSPCNS Pharmaceuticals Inc	US$ 0.11987 (-2.54%)	246.67M
BOXLBoxlight Corporation	US$ 1.645 (257.61%)	240.38M
SPRCSciSparc Ltd	US$ 1.06 (100.80%)	190.41M